Skip to main content

HRI's breakthrough drug on China Global Television Network

HRI talks to Channel 7 News about breakthrough drug

The revolutionary new anti-clotting medicine developed by Heart Research Institute researchers may hold the key to controlling the deadly blood clots caused by COVID-19.

This groundbreaking research has attracted national and international media interest due to its far-reaching impact.

Following successful phase 1 trials that demonstrated the drug’s safety in otherwise healthy patients, HRI researchers led by Professor Shaun Jackson want to urgently move into global phase 2 trials, testing the effectiveness and safety of the drug in critically ill COVID-19 patients. It could then be a matter of months before doctors around the world can use the novel anti-clotting drug to protect patients with COVID-19, potentially saving thousands of lives.

“We need to act now, and we are urgently seeking funding to get trials underway,” Professor Jackson said.

If Professor Jackson’s clinical trials are successful, his team’s innovative anti-clotting medicine could put Sydney-based medical research on the map and become a global blockbuster therapy for patients suffering COVID-19, stroke or heart disease.

Global news coverage

News coverage in Australia

Published 9–12 June 2020

Published 23 June 2020

Radio coverage in Australia

  • Mix 104.9
  • 990 AM 4RO
  • FIVEaa
  • Hot 100 FM
  • 981 2NM
  • Power FM Nowra
  • 2EC East Coast Radio
  • Radio 2ST Highlands
  • Radio 2ST Coast
  • Power FM Bega Bay
  • Eagle FM 93.5 2SNO
  • 3BA FM
  • Power FM 103.1
  • 93.9 Bay FM
  • K-Rock 95.3
  • 4CA 846 AM
  • Power 100.7 FM
  • 4MK 1026 AM
  • 4BU Classic Hits
  • River 94.9 FM
  • Zinc 96.1
  • Hitz FM 93.9
  • 4CC
  • K-Rock 95.5

Support HRI

Today's research is tomorrow's cure.

Every donation to the Heart Research Institute is an investment into the lives of millions. Help make a lasting difference by donating today.

Other ways you can help

Tax receipts will be sent from July 6.